Ralph S. Freedman

Medicine · Health Sciences

48h-index7.1kcitations226works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(58), Immunotherapy and Immune Responses(51), Immune Cell Function and Interaction(45), Endometrial and Cervical Cancer Treatments(26), Reproductive System and Pregnancy(21)

Publications226 total

Considerazioni a proposito di "Alba", la trasformazione di Wiesel da vittima a assassino
GRUPPI·2025
Supplementary Figure Legends 1-3, Table Legend 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Table 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Figure 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Figure 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Data from Common Cancer Biomarkers
2023Open Access
Data from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Data from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Table from Common Cancer Biomarkers
2023Open Access
Supplementary Table 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Figure 2 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Data from Common Cancer Biomarkers
2023Open Access
Supplementary Table from Common Cancer Biomarkers
2023Open Access
Supplementary Figure Legends 1-3, Table Legend 1 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Supplementary Figure 2 from Plasmacytoid Dendritic Cells Promote Immunosuppression in Ovarian Cancer via ICOS Costimulation of Foxp3<sup>+</sup> T-Regulatory Cells
2023Open Access
Disseminating universal genetic testing to a diverse, indigent patient population at a county hospital gynecologic oncology clinic
Gynecologic Oncology·2018· 13 citedOpen Access
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression
Cancers·2018· 47 citedOpen Access
Successful implementation of universal genetic testing in a county hospital gynecologic oncology clinic: A quality improvement initiative
Gynecologic Oncology·2018
2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center
Clinical Cancer Research·2016· 13 citedOpen Access
Early-Stage Ovarian Cancer
2014· 2 cited
page 1 of 12Next →

Frequent Co-authors

Claire F. Verschraegen(15), Andrzej P. Kudelka(13), Creighton L. Edwards(13), John J. Kavanagh(13), Chris D. Platsoucas(10), Bohuslav Melichar(8), J. J. Kavanagh(7), Ena Wang(7), Michael T. Deavers(6), Saroj Vadhan‐Raj(4), Francesco M. Marincola(4), Rebecca Patenia(4), M Hord(3), David M. Gershenson(3), M Steger(3), A P Kudelka(3), Michael Nash(3), Monica C. Panelli(3), E. Neely Atkinson(3), Stacie Templin(3)